BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36032664)

  • 1. The UBC9/SUMO pathway affects E-cadherin cleavage in HPV-positive head and neck cancer.
    Sabatini ME; Compagnoni M; Maffini F; Miccolo C; Pagni F; Lombardi M; Brambilla V; Lepanto D; Tagliabue M; Ansarin M; Citro S; Chiocca S
    Front Mol Biosci; 2022; 9():940449. PubMed ID: 36032664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression.
    Umbreit C; Flanjak J; Weiss C; Erben P; Aderhold C; Faber A; Stern-Straeter J; Hoermann K; Schultz JD
    Anticancer Res; 2014 Dec; 34(12):7061-9. PubMed ID: 25503133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
    St John MA
    Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-cadherin expression is involved in malignant behavior of head and neck cancer in relation to epithelial-mesenchymal transition.
    Nguyen PT; Kudo Y; Yoshida M; Kamata N; Ogawa I; Takata T
    Histol Histopathol; 2011 Feb; 26(2):147-56. PubMed ID: 21154228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow mesenchymal stem cells promote head and neck cancer progression through Periostin-mediated phosphoinositide 3-kinase/Akt/mammalian target of rapamycin.
    Liu C; Feng X; Wang B; Wang X; Wang C; Yu M; Cao G; Wang H
    Cancer Sci; 2018 Mar; 109(3):688-698. PubMed ID: 29284199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of epithelial-mesenchymal transition and loss of podoplanin expression are associated with progression of lymph node metastases in human papillomavirus-related oropharyngeal carcinoma.
    Wakisaka N; Yoshida S; Kondo S; Kita M; Sawada-Kitamura S; Endo K; Tsuji A; Nakanish Y; Murono S; Yoshizaki T
    Histopathology; 2015 May; 66(6):771-80. PubMed ID: 25039283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-Mesenchymal Transition Predicts Survival in Oral Squamous Cell Carcinoma.
    Wangmo C; Charoen N; Jantharapattana K; Dechaphunkul A; Thongsuksai P
    Pathol Oncol Res; 2020 Jul; 26(3):1511-1518. PubMed ID: 31471883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of DNMT 3B promotes epithelial-mesenchymal transition and gene expression profile of invasive head and neck squamous cell carcinomas cell lines.
    Chen LH; Hsu WL; Tseng YJ; Liu DW; Weng CF
    BMC Cancer; 2016 Jul; 16():431. PubMed ID: 27391030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoexpression of Epithelial Mesenchymal Transition Proteins E-Cadherin, β-Catenin, and N-Cadherin in Oral Squamous Cell Carcinoma.
    Angadi PV; Patil PV; Angadi V; Mane D; Shekar S; Hallikerimath S; Kale AD; Kardesai SG
    Int J Surg Pathol; 2016 Dec; 24(8):696-703. PubMed ID: 27312520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-Mesenchymal Transition during Metastasis of HPV-Negative Pharyngeal Squamous Cell Carcinoma.
    Ihler F; Gratz R; Wolff HA; Weiss BG; Bertlich M; Kitz J; Salinas G; Rave-Fränk M; Canis M
    Biomed Res Int; 2018; 2018():7929104. PubMed ID: 29693014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma.
    Fujii R; Imanishi Y; Shibata K; Sakai N; Sakamoto K; Shigetomi S; Habu N; Otsuka K; Sato Y; Watanabe Y; Ozawa H; Tomita T; Kameyama K; Fujii M; Ogawa K
    J Exp Clin Cancer Res; 2014 May; 33(1):40. PubMed ID: 24887090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
    Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
    Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic antitumour activity of HDAC inhibitor SAHA and EGFR inhibitor gefitinib in head and neck cancer: a key role for ΔNp63α.
    Citro S; Bellini A; Miccolo C; Ghiani L; Carey TE; Chiocca S
    Br J Cancer; 2019 Mar; 120(6):658-667. PubMed ID: 30765872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC).
    Pectasides E; Rampias T; Sasaki C; Perisanidis C; Kouloulias V; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
    PLoS One; 2014; 9(4):e94273. PubMed ID: 24722213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer.
    Lee J; You JH; Kim MS; Roh JL
    Redox Biol; 2020 Oct; 37():101697. PubMed ID: 32896720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate Transglutaminase (TGase-4) Induces Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells.
    Ablin RJ; Owen S; Jiang WG
    Anticancer Res; 2017 Feb; 37(2):481-487. PubMed ID: 28179293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The upregulated α-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition.
    Zhang Z; Yang XF; Huang KQ; Ren L; Zhao S; Gou WF; Shen DF; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2016 Feb; 37(2):1671-81. PubMed ID: 26311049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-cadherin expression is correlated with metastasis of spindle cell carcinoma of head and neck region.
    Nguyen PT; Kudo Y; Yoshida M; Iizuka S; Ogawa I; Takata T
    J Oral Pathol Med; 2011 Jan; 40(1):77-82. PubMed ID: 21070371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV-mediated regulation of SMAD4 modulates the DNA damage response in head and neck cancer.
    Citro S; Miccolo C; Medda A; Ghiani L; Tagliabue M; Ansarin M; Chiocca S
    J Exp Clin Cancer Res; 2022 Feb; 41(1):59. PubMed ID: 35144669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma.
    Lai YJ; Yu WN; Kuo SC; Ho CT; Hung CM; Way TD; Chen CT
    J Cell Physiol; 2019 Jun; 234(6):9118-9129. PubMed ID: 30341909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.